Tubeless
Insulin Pump Market, by Component (Pod/Patch, Remote, and Accessories), and
by End User (Hospitals, Pharmacies, and E-Commerce) - Global Industry Insights,
Trends, Outlook, and Opportunity Analysis 2018-2026
Tubeless insulin pump is a
portable pump, which is effective in controlling blood glucose level.
Advancements in technologies of insulin pumps, which reduce the need for daily
insulin injection doses is expected to boost growth of the tubeless insulin
pump market over the forecast period. Omnipod, by Insulet Corporation is
expected to drive the growth of insulin pumps in near future. Omnipod is a
novel tubeless insulin pump, which displays blood glucose levels, schedules
insulin delivery, and calculates optimal insulin dosage based on food database.
Furthermore, Insulet Corporation has recently added additional features such as
touchscreen and Bluetooth to Omnipod Dash system. Portability offered by these
devices permits easy attachment and placements of the device on clothing or
desired body parts, which is expected to drive growth of the tubeless insulin
pump market.
Increasing funding by the
government for studying various diseases including diabetes is also expected to
fuel growth of the tubeless insulin pump market. For instance, in 2013,
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) funded
several important studies on different types of artificial pancreas devices to
help patients suffering from type 1 and type 2 diabetes and gestational
diabetes. Insulin pumps have gained traction, owing to the rapid acting
mechanism offering instant insulin delivery, user friendly interface, and
flexible insulin delivery, which is expected to fuel growth of the tubeless
insulin pump market over the forecast period.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1298
Increasing prevalence of diabetes
and robust development in technology is expected to drive growth of the market
over the forecast period
Increasing prevalence of diabetes
due to obesity and increasing geriatric population is driving demand for
tubeless insulin pump market. According to the World Health Organization, 2016,
an estimated 422 million adults were suffering from diabetes globally. New
technologies incorporated into tubeless insulin pump devices is leading to
increasing demand for insulin pump devices worldwide. Market players are
focused on developing new technologies in tubeless insulin pump devices, which
can be used at home with ease and with accurate results, this in turn is
expected to boost overall market growth during the forecast period. For
instance, in 2016, in the U.K., Medtrum Technologies, Inc. launched S6
Easysense Disposable CGM System, which provides interstitial glucose levels in
every two minutes and P6 Tubeless Patch Pump, which is ideal for type 2
diabetes management and gestational diabetes. It also allows monitoring of data
using mobile app. However, high long-term cost associated with the use of
tubeless insulin pump hampers the market growth. Compliance to therapy reduces
over the time, owing to significant cost associated with daily use.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/tubeless-insulin-pump-market-1298
On the basis of geography, North
America is expected to dominate the tubeless insulin pump market, followed by
Europe, owing to high adoption rate for new technology and continuous
government initiatives to create awareness regarding diabetes. For instance, in
2016, the American Diabetes Association (ADA) recommended diabetes education,
training on the device, and providing support after prescription of Continuous
Glucose Monitoring (CGM) and insulin pump. Market in Asia Pacific is lucrative
in terms of market opportunities due to increase in research and development
activities by various vendors and implementation of government initiatives for
diabetic patients. For instance, in 2017, National Diabetes Services Scheme
(NDSS) initiated by Australian Government funded Insulin Pump Programme to
increase the affordability of insulin pumps to for people suffering from type 1
diabetes who don’t have access to private health insurance.
Major players operating in the
tubeless insulin pump market include Medtronic Plc., Medtrum Technologies,
Inc., Tandem Diabetes Care, Insulet Corporation, and Animas Corporation.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1298
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment